Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
32
33
Next >
Biotech Stock Travere Therapeutics Is Trading At A Deep Discount: JPMorgan
July 21, 2023
Tickers
TVTX
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks
July 17, 2023
Tickers
ABOS
ARKG
BBIO
IBB
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Current Analysis: Eisai Co Ltd (ESAIY)
July 16, 2023
Tickers
ESAIY
ESALF
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Week In Review: BeiGene Options DualityBio ADC In $1.3 Billion Agreement
July 15, 2023
Tickers
BNTX
WXXWY
Tags
Market News
Pharma/Biotech
From
TalkMarkets
Psychedelic Compound-Based Drug Stocks Up 12% MTD; Now Up 25% YTD
July 14, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Psychedelic Stocks Jumped 10% Last Week
July 09, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
Week In Review: Billion Dollar Deals - Moderna’s Shanghai Investment And F-Star’s Takeda Collaboration
July 08, 2023
Tickers
ARGX
BRIBF
IVBXF
MRNA
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Thoughts For Thursday: Back From The Holiday With Caution
July 06, 2023
Tickers
BWA
CRSP
DAX
GERN
Tags
Pharma/Biotech
Technology
Consumer Goods
From
TalkMarkets
Biotech Blues: Stay Balanced Through July Earnings Season
July 05, 2023
Tickers
AZN
IBB
LLY
QQQ
Tags
ETFs
Healthcare
Market News
From
TalkMarkets
Stocks May Suffer With Rates On The Cusp Of A Surge Higher
July 03, 2023
Tickers
FXE
NDX
SPTL
SPX
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Week In Review: CMBG Out-Licenses Two CAR-T Candidates To Janssen For $245 Million Upfront
July 01, 2023
Tickers
BPMC
BRIBF
IVBXF
MRK
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
Upward Trend In Largest Psychedelic Compound-Based R&D Stocks Continues
July 01, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
Large Cap Biopharma Buffeted By Big Gov, Choppy Days Ahead
June 26, 2023
Tickers
AZN
MRK
REGN
UNH
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
What Is CRISPR And Why Should Your Portfolio Care?
June 25, 2023
Tickers
CRSP
EDIT
NTLA
NVS
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Week In Review: AstraZeneca Considers Spinning Off China Ops Into Separate Company
June 24, 2023
Tickers
AZN
CALT
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
MRK: Garner Income From This Pharma Giant
June 24, 2023
Tickers
MRK
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
TalkMarkets Announces Company Spotlight Featuring Evogene
June 22, 2023
Tickers
EVGN
Tags
Pharma/Biotech
Market News
From
TalkMarkets
Evogene - A Company With Valuable Assets Trading At Zero Enterprise Value
June 22, 2023
Tickers
ARKG
CTVA
EVGN
ICL
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
Biotech And Healthcare Stocks Lagging
June 21, 2023
Tickers
ABBV
IBB
LLY
MRK
Tags
Healthcare
ETFs
Stocks / Equities
From
TalkMarkets
Week In Review: Cullgen Signs $1.9 Billion Protein Degrader Deal With Astellas
June 17, 2023
Tickers
ALPMY
AZN
CHSYF
IVBXF
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities
June 17, 2023
Tickers
ALNY
CRSP
INCY
IONS
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
Upward Trend In Major Psychedelic Compound-Based Research & Development Stocks Continue
June 17, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
Tuesday Talk: Not Clear Yet
June 13, 2023
Tickers
ABBV
AMD
APA
CCL
Tags
Energy
Consumer Goods
Technology
From
TalkMarkets
Macro Muddle Coming Up As Market Exceeds Expectations, Small Caps Gain Ground
June 12, 2023
Tickers
AAPL
AZN
BIIB
GOOGL
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
Major Psychedelic Compound-Based Research & Development Stocks: June Update
June 10, 2023
Tickers
CMPS
GHRS
IXHL
MNMD
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Week In Review: Shanghai HighTide Therapeutics Files For Hong Kong IPO
June 10, 2023
Tickers
BNTX
GRCL
IVBXF
LEGN
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Chart Of The Day: Protagonist Therapeutics - Wide Opinions
June 09, 2023
Tickers
PTGX
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Bullish Sequence Will Fuel Novo Nordisk To More Upside
June 07, 2023
Tickers
NVO
Tags
Healthcare
Pharma/Biotech
Market News
From
TalkMarkets
Market Mixes It Up With A Broad Rally
June 05, 2023
Tickers
ABOS
EVH
GERN
IWM
Tags
Healthcare
ETFs
Stocks / Equities
From
TalkMarkets
Week In Review: Betta Pharma Enters $392 Million Deal For C4 Therapeutics’ NSCLC Drug
June 03, 2023
Tickers
CCCC
CNTB
MIRM
SBHMY
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.